Zhuang Yongze, Liu Bo, Yu Yinghao, Guan Tianjun, Zheng Zhiyong, Chen Anqun
Department of Nephrology, 900 Hospital of the Joint Logistics Team, PLA, Fuzhou General Clinical Medical College of Fujian Medical University, Fuzhou, China.
Department of Pathology, 900 Hospital of the Joint Logistics Team, PLA, Fuzhou General Clinical Medical College of Fujian Medical University, Fuzhou, China.
Kidney Dis (Basel). 2021 Jan;7(1):67-77. doi: 10.1159/000509088. Epub 2020 Aug 26.
Intrarenal arterial lesions (IALs) have been studied in immunoglobulin A nephropathy and lupus nephritis, but this has not been reported in hepatitis B virus-associated glomerulonephritis (HBV-GN). This study aims to investigate the prevalence and the role of IALs in HBV-GN.
IALs were examined in kidney biopsy specimens from 205 patients with HBV-GN retrospectively. The severity of IALs and tubular interstitial lesions was scored semi-quantitatively. The severity of IALs was divided into 4 groups on the basis of ILA score, which were no IALs (Score 0), mild IALs (Score 1-2), moderate IALs (Score 3-4), and severe IALs (Score 5-10) groups. Survival analysis was performed using the Kaplan-Meier method between the severity of IALs and clinical events (doubling of serum creatinine [SCr], ESRD, and death due to the kidney disease).
Among 205 patients with HBV-GN, 143 (69.8%) had IALs in their kidney biopsy specimens. IALs were mild in 28 (19.6%) patients, moderate in 101 (70.6%) patients, and severe in 14 (9.8%) patients. The severity of IALs was associated with high blood pressure (BP), high SCr, and severe tubulointerstitial injuries. The average follow-up time of these 205 HBV-GN patients was 94.2 ± 47.1 months, in which 46 cases had clinical event. The proportions of clinical events in no IAL, mild IAL, moderate IAL, and severe IAL groups were 9.7, 14.3, 25.7, and 71.4%, respectively. Event-free survival of patient in IAL group was significantly lower than that in the no IAL group ( = 0.000). Multivariate cox regression analysis indicated SCr (1.011, 1.007-1.016), hypertension (1.767, 1.004-3.108), and IAL (2.194, 1.062-4.530) were independent risk factors for clinical events after adjustment for age and gender. Event-free clinical survival in moderate and severe IAL groups was significantly lower than that in the no IAL group ( = 0.0111 and = 0.0001, respectively). Besides, event-free renal survival in severe IAL group was significantly lower than that in moderate IAL group ( = 0.009). Multivariate cox regression analysis showed that the more severe the IALs, the higher the risk of the clinical event, with a hazard ratio of 2.284 for moderate IALs (1.085-4.907) and 3.315 for severe IALs (1.296-8.482).
Severity of IALs is associated with high BP, reduced renal function, and poor clinical prognosis in HBV-GN patients.
肾内动脉病变(IALs)已在免疫球蛋白A肾病和狼疮性肾炎中得到研究,但在乙型肝炎病毒相关性肾小球肾炎(HBV-GN)中尚未见报道。本研究旨在调查IALs在HBV-GN中的患病率及其作用。
回顾性分析205例HBV-GN患者肾活检标本中的IALs。对IALs和肾小管间质病变的严重程度进行半定量评分。根据ILA评分将IALs的严重程度分为4组,即无IALs(评分0)、轻度IALs(评分1 - 2)、中度IALs(评分3 - 4)和重度IALs(评分5 - 10)组。采用Kaplan-Meier法对IALs严重程度与临床事件(血清肌酐[SCr]翻倍、终末期肾病[ESRD]和肾病死亡)进行生存分析。
205例HBV-GN患者中,143例(69.8%)肾活检标本中有IALs。28例(19.6%)患者IALs为轻度,101例(70.6%)患者为中度,14例(9.8%)患者为重度。IALs的严重程度与高血压(BP)、高SCr和严重的肾小管间质损伤相关。这205例HBV-GN患者的平均随访时间为94.2±47.1个月,其中46例发生临床事件。无IALs、轻度IALs、中度IALs和重度IALs组的临床事件发生率分别为9.7%、14.3%、25.7%和71.4%。IALs组患者的无事件生存率显著低于无IALs组(P = 0.000)。多因素cox回归分析表明,在调整年龄和性别后,SCr(1.011,1.007 - 1.016)、高血压(1.767,1.004 - 3.108)和IALs(2.194,1.062 - 4.530)是临床事件的独立危险因素。中度和重度IALs组的无事件临床生存率显著低于无IALs组(分别为P = 0.0111和P = 0.0001)。此外,重度IALs组的无事件肾脏生存率显著低于中度IALs组(P = 0.009)。多因素cox回归分析显示,IALs越严重,临床事件风险越高,中度IALs的风险比为2.284(1.085 - 4.907),重度IALs为3.315(1.296 - 8.482)。
IALs的严重程度与HBV-GN患者的高血压、肾功能下降和不良临床预后相关。